로딩 중…
지수 로딩 중…
Ocular Therapeutix, Inc.
OCUL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$9.43-2.18%
2026-06-18
Price Chart
Ocular Therapeutix, Inc.+13.21%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.06B |
| Revenue | $52M |
| Net Income | $-290M |
| Total Assets | $733M |
| Net Assets | $582M |
| Value | |
| P/B | 3.55x |
| P/S | 39.68x |
| FCF Yield | -11.67% |
| Profitability | |
| ROE | -49.95% |
| ROA | -39.66% |
| Op. Margin | -575.42% |
| Revenue Growth | 0.81% |
| Financial Health | |
| Debt Ratio | 25.96% |
| Total Debt | $79M |
| FCF | $-241M |
| Cash | $667M |
| Current Ratio | 14.81x |
| Performance | |
| 1Y Return | 13.21% |
| 1M Return | 18.02% |
| From 52W High | -42.64% |
| 1Y MDD | -57.29% |
| Trading | |
| Volume | 6,014,188 shares |
| Trading Value | $59M |
| Per Share | |
| EPS | $-1.19 |
| BPS | $2.94 |